PURPOSE: Introduction of the prostate specific antigen (PSA) serum marker for prostate
cancer and the subsequent PSA era from 1988 to the present have dramatically altered the …

The introduction of prostate-specific membrane antigen (PSMA) in clinical practice has
revolutionized evaluation of biochemical recurrence of prostate cancer after curative-intent …

Purpose: Standard diagnostic methods are limited for detecting distant metastases in
patients with prostate cancer in whom the only evidence of disease after radical …

Imaging is a critical component of diagnosis, staging and monitoring, all of which factor
heavily in treatment decision-making for cancer patients. Agents, such as antibodies, can …

BACKGROUND Optimum therapy for prostate carcinoma patients requires accurate staging,
but computed tomography (CT) and magnetic resonance imaging (MRI) have limitations as …

Objectives. To report the results of a retrospective study of 2290 ProstaScint scans of 2154
patients with prostate carcinoma done at 15 institutions. Methods. The results were analyzed …

BACKGROUND Primary extraprostatic spread or failure after prostate cancer treatment can
occur locally in the prostatic fossa and/or metastasize to regional and/or distant lymphatics …

OBJECTIVE. The purpose of this article is to discuss the epidemiology, risk factors, and
presentation of prostate cancer. After reviewing the prostate anatomy, the article will show …

Circulating tumor cells (CTCs) can provide a non-invasive, repeatable snapshot of an
individual patient's tumor. In prostate cancer, CTC enumeration has been extensively …

Background. The cervical nodes have been excluded from the category of reginal nodes in
cases of thoracic esophageal cancer in the present TNM classifications. Methods. One …